Tradestie Institutional Equity Comparison Engine
PRLB vs VIVS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PRLB Overall Edge
PRLB Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Proto Labs, Inc. (PRLB) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PRLB trades at 25.0x Forward P/E with 8.1% operating margin (+14.0% YoY revenue) versus VIVS at N/M Forward P/E and -10117.0% operating margin (-51.4% YoY). In options structure, PRLB sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro) against VIVS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
PRLB
PRLB 25.0x vs VIVS N/M Fwd P/E
Growth & Margin Winner
PRLB
Op Margin 8.1% vs -10117.0% ยท YoY +14.0% vs -51.4%
Momentum & Technical Winner
PRLB
1Y +33.4% vs -87.0% ยท 52W Pos 31% vs 5%
Options & Structure Winner
PRLB
CONSOLIDATION (9th %ile IV) vs BREAKDOWN (N/A IV)
PRLB
NYSE
Proto Labs, Inc.
Fabricated Structural Metal Products
$62.89
-1.57% 1D
Market Cap
$1.5B
1M Return
-29.88%
1Y Return
+33.35%
Forward P/E
25.0x
Unified AI Score
62.1 / 100
BUY
Tech 78.0
Fund 69.0
Flow 54.0
Mom 60.0
VIVS
NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap
$2.4M
1M Return
+64.69%
1Y Return
-86.99%
Forward P/E
N/M
Unified AI Score
36.8 / 100
SELL
Tech 5.0
Fund 38.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PRLB +33.35%
VIVS -86.99%
Spread: +120.34 pp (PRLB Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PRLB Revenue | VIVS Revenue | PRLB Op. Margin | VIVS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $460M | $0M | 17.4% | -882.4% | PRLB |
| FY2020 | $430M | $0M | 13.8% | -977.9% | PRLB |
| FY2021 | $490M | N/A | 8.3% | N/A | PRLB |
| FY2022 | $490M | $0M | -20.1% | -765.3% | PRLB |
| FY2023 | $500M | $0M | 5.6% | -4792.2% | PRLB |
| FY2024 | $500M | $0M | 4.0% | -13840.4% | PRLB |
| FY2025 | $530M | $0M | 4.7% | -8761.1% | PRLB |
| FY2026 | N/A | $0M | N/A | -8768.7% | VIVS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PRLB | VIVS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.5B | $2.4M | Larger Scale | PRLB |
| Trailing P/E Ratio Valuation | 43.8x | N/M | Lower Multiple | PRLB |
| Forward P/E Ratio Valuation | 25.0x | N/M | Lower Multiple | PRLB |
| Revenue Growth (YoY) Growth | +14.0% | -51.4% | Higher Growth | PRLB |
| Operating Margin (TTM) Profitability | 8.1% | -10117.0% | Higher Margin | PRLB |
| Net Profit Margin Profitability | 6.0% | 0.0% | Higher Margin | PRLB |
| Return on Equity (ROE) Capital Efficiency | 5.1% | -343.1% | Higher ROE | PRLB |
| 52-Week Range Position Momentum | 31% ($46โ$100) | 5% ($0โ$3) | Stronger Trend | PRLB |
| Beta / 30D Volatility Risk Regime | 1.85ฮฒ ยท 75% Vol | 0.83ฮฒ ยท 480% Vol | Lower Realized Risk | PRLB |
| Unified Institutional Score Composite Signal | 62.1 / 100 (BUY) | 36.8 / 100 (SELL) | Higher Composite | PRLB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PRLB vs VIVS Buy Guide
PRLB
CONSOLIDATION
106d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
VIVS
BREAKDOWN
73d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PRLB nor VIVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.